Summary.-Biopsy specimens from nasopharyngeal carcinomas (NPC) or salivarygland carcinomas (SGC) in Greenland Eskimoes were examined for the presence of Epstein-Barr virus (EBV) DNA and sera from the patients were tested for EBVspecific antibody titres. Six out of 7 NPCs and one from an undifferentiated SGC were positive for EBV DNA. The EBV-specific antibody spectra and titres of the patients with NPC or undifferentiated SGC conformed to the results of earlier studies in other high-incidence areas.
THE EPSTEIN-BARR VIRUS (EBV) was originally detected in cultured African
Burkitt's lymphoma (BL) cells in 1964 (Epstein et al., 1964 (Epstein et al., , 1965 . Two years later tests for EBV-specific precipitating antibodies suggested an association of the virus with nasopharyngeal carcinoma (NPC) in East African and American patients (Old et al., 1966) . It was rapidly shown thereafter that NPC patients had elevated titres of IgG antibodies to EBV viral capsid antigen (VCA) and to the diffuse (D) component of the early-antigen (EA) complex (Henle et al., 1970 (Henle et al., , 1971 (Henle et al., , 1977 . IgA antibodies to these 2 antigens were also often demonstrable in sera from NPC patients (Henle & Henle, 1976; Henle et al., 1977) . This pattern of elevated IgG and IgA antibodies to VCA and EA (D) has been found uniformly in NPC patients, whether from low-or high-risk areas (Henle & Henle, 1976; Henle et al., 1977; de The et al., 1978; Klein, 1979; Lanier et al., 1981) . The association of NPC with EBV has been further strengthened by the detection of EBV genomes in the malignant epithelial cells by nucleicacid hybridization techniques (zur Hausen et al., 1970 (zur Hausen et al., , 1974 Nonoyama et al., 1973; Wolf et al., 1973 Wolf et al., , 1975 and by demonstration of EBV nuclear antigen (EBNA) in the carcinoma cells (Huang et al., 1974; Klein et al., 1974) . Recently Anderson-Anvret et al. (1977 have shown that the regular association of EBV with NPC holds good for the undifferentiated or non-keratinizing type (WHO-2 and WHO-3 classification) which dominate in high-risk areas (Clifford & Beecher, 1964; Schmauz & Templeton, 1972; Nielsen et al., 1977) , but not for well-differentiated tumours (WHO-1).
Sero -epidemiological studies have demonstrated a worldwide distribution of EBV, more than 90% of all adults being seropositive (llcile & Henle, 1979a (Schafer et al., 1975; Lanier et al., 1976; Nielsen et al., 1977;  de .
In Greenland, which has more than 40,000 inhabitants of Eskimo ancestry, the incidence of NPC per 100,000 has recently been found to be 12 3 for males and 8-5 for females (Nielsen et al., 1977) . Thus the frequency of NPC in Greenland is among the highest on record. Another cancer, salivary-gland carcinoma (SGC), has a high incidence among Greenlandic Eskimoes: 3 9 for males and 7 7 for females. More than 90°/% of these tumours are located in the parotid gland and at the histopathological level they appear to be indistinguishable from undifferentiated NPC (Nielsen et al., 1978) . It was thus of interest to examine not only the association of EBV with NPC, but also with SGC in Greenland. The populationi structure and medical facilities in Greenland have been described previously (Nielsen et al., 1977 (Henle et al., 1974 : Henle & Henle, 1976 . Antibodies to R cannot be measured in the presence of D immunofluorescence unless thev exceed in titre the anti-D level (Henle et al., 1971) . Antibody titres to EBNA were determined by anti-C' immunofluorescence as previously described (Reedman & Klein. 1973) .
EBV DNA for nucleic-acid lhybridization was prepared as described by Adams (1975) Lindahl et al. (1976) and 32P-labelled virus DNA (vDNA) by nick-translation as previously described (Rymo, 1979) . The isolation of cellular DNA (Petterson & Sambrook. 1973 ) and the use of cRNA-DNA filter hybridization and vDNA-DNA reassociation kinetic analysis, for the determination of the number of EBV genome equivalents, has been described in detail elsew%here (Lindahl et al., 1976; Anderson-Anvret et al.. 1977 : Saemundsen et al., 1981 .
RESULTS

Nasopharyngeal carcinoma
All 10 patients were clinically in Stage IV. Two demonstrated undifferentiated carcinomas in all 10 patients (Figs la, b). In 6/10 cases nucleic -acid hybridization with cRNA revealed 2-50 EBV genome equivalents per cell (Table I ). In one case (K.G.) retested by vDNA reassociation kinetic analysis, 9 genome equivalents were detected (Fig. 2) . In 3 cases the hybridization could not be performed due to technical failures and 1 other case gave a negative result. In this last case the specimen used for histopathology con- (Table I) .
Salivary gland carcinomas
Of the 3 patients studied, 2 had an operable and 1 an inoperable tumour of the parotid gland. In 2 cases the histopathological appearance was compatible with that of typical undifferentiated NPC (Figs. 3a, b) . The third tumour was a poorly differentiated adenocarcinoma. In every case a biopsy sample of the nasopharyngeal mucosa on the same side as the parotid tumour, obtained as control, contained no tumour tissue.
Nucleic-acid hybridization was performed on the adenocarcinoma and one of the undifferentiated carcinomas. cRNA-DNA filter hybridization (Table II) and vDNA reassociation kinetic analysis (Fig.  4) demonstrated a significant number of EBV genome equivalents in the undifferentiated carcinoma. No EBV genomes could be detected in the adenocarcinoma. (Table II ; Fig. 4) .
Sera from the patients with undifferentiated carcinomas showed patterns of EBV-specific antibodies within the range seen in NPC patients. In the patient with the adenocarcinoma, only VCA and EBNA antibodies were detected (Table II) Eskimoes. Furthermore, the serological profiles covered the same range as found elsewhere in patients from high-risk areas (Henle et al., 1970 (Henle et al., , 1971 (Henle et al., , 1977 Henle & Henle, 1976; de The et al., 1978; Lanier et al., 1981 Nielsen et al., 1978) . Over a 20-year period 920 of malignant salivary-gland neoplasms in Greenland were identified as undifferentiated carcinomas (Nielsen et al., 1978 (Henle & Henle, 1979a (Nielsen et al., 1978; Lanier et al., 1981) but, in the 3 cases described here, biopsy samples from the nasopharynx contained no tumour tissue. EBV is the causative agent of infectious mononucleosis (Henle & Henle, 1979b) and is uniquely associated with BL (Epstein & Achong, 1979) and NPC (AndersonAnvret et al., 1978; Klein, 1979) . Recently, a link has also been demonstrated between EBV and certain lymphoproliferative disorders that occur in patients with inherited or acquired immunodeficiencies (Saemundsen et al., 1981 STEHLIN, J. (1974) 
